- Home
- CREV vs BGLC Comparison
CREV vs BGLC Comparison
Compare CREV & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- BGLC
- Stock Information
- Founded
- CREV 2007
- BGLC 2017
- Country
- CREV Ireland
- BGLC Malaysia
- Employees
- CREV N/A
- BGLC N/A
- Industry
- CREV
- BGLC Medical Specialities
- Sector
- CREV
- BGLC Health Care
- Exchange
- CREV Nasdaq
- BGLC Nasdaq
- Market Cap
- CREV 8.8M
- BGLC 7.6M
- IPO Year
- CREV N/A
- BGLC N/A
- Fundamental
- Price
- CREV $2.99
- BGLC $0.30
- Analyst Decision
- CREV Strong Buy
- BGLC
- Analyst Count
- CREV 1
- BGLC 0
- Target Price
- CREV $39.00
- BGLC N/A
- AVG Volume (30 Days)
- CREV 58.6K
- BGLC 78.7K
- Earning Date
- CREV 01-01-0001
- BGLC 11-20-2024
- Dividend Yield
- CREV N/A
- BGLC N/A
- EPS Growth
- CREV N/A
- BGLC N/A
- EPS
- CREV N/A
- BGLC N/A
- Revenue
- CREV $39,261,077.00
- BGLC $9,183,168.00
- Revenue This Year
- CREV $40.76
- BGLC N/A
- Revenue Next Year
- CREV $86.18
- BGLC N/A
- P/E Ratio
- CREV N/A
- BGLC N/A
- Revenue Growth
- CREV 41.52
- BGLC N/A
- 52 Week Low
- CREV $2.61
- BGLC $0.28
- 52 Week High
- CREV $46.00
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- CREV 34.46
- BGLC 24.52
- Support Level
- CREV $3.02
- BGLC $0.32
- Resistance Level
- CREV $4.53
- BGLC $0.38
- Average True Range (ATR)
- CREV 0.46
- BGLC 0.02
- MACD
- CREV 0.02
- BGLC -0.00
- Stochastic Oscillator
- CREV 19.80
- BGLC 18.27
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.